WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Thursday reported a loss of $58.6 million in its fourth quarter.

On a per-share basis, the West Conshohocken, Pennsylvania-based company said it had a loss of $2.57.

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.

The biopharmaceutical company posted revenue of $321.1 million in the period, topping Street forecasts. Six analysts surveyed by Zacks expected $313.4 million.

For the year, the company reported a loss of $288.3 million, or $12.85 per share. Revenue was reported as $958.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL